Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
All medications come with potential risks and side effects
WADA Prohibition While GLP1 and cagrilintide individually have not been explicitly listed by WADA, several considerations apply: GLP-1 agonist precedent Other GLP-1 agonists are monitored for potential misuse in athletics Weight-class sports concern Rapid weight reduction capabilities raise concerns for sports with weight classifications Performance-enhancing potential Metabolic effects could theoretically affect athletic performance Monitoring program possible May be added to WADA monitoring program as use increases Athletes should consult with their sports governing bodies and anti-doping authorities before considering any GLP-1 or amylin analogue use
That is why supporting healthy glutathione levels is important, to help keep skin protected from within and maintain a brighter, healthier-looking complexion
224.08 SAVE 11.79 Including VAT, plus shipping costs
